Uncategorized

Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology

Anixa Biosciences, Inc. today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance broadening protection of Anixa’s novel ovarian cancer vaccine technology, which has been exclusively licensed from, and is being developed in partnership with, Cleveland Clinic.  

Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology Read More »

Acceptance Of Clinical Trial Application For The Recbio’s Novel Adjuvanted Recombinant Shingles Vaccine REC610 In China And Overseas Clinical Trial Progress

Jiangsu Recbio Technology Co., Ltd. is pleased to announce that the Group has recently received the notice of acceptance issued by National Medical Products Administration, pursuant to which the clinical trial application for its self-developed novel adjuvanted recombinant shingles vaccine REC610 has been accepted.

Acceptance Of Clinical Trial Application For The Recbio’s Novel Adjuvanted Recombinant Shingles Vaccine REC610 In China And Overseas Clinical Trial Progress Read More »

La ciencia del color en el diseño web: Cómo los colores influyen en la percepción y la experiencia del usuario

La ciencia del color en el diseño web es un área fascinante y altamente subestimada que tiene el poder de influir fuertemente en la percepción y la experiencia del usuario. Este aspecto crucial de la estética y la funcionalidad de un sitio web tiene el potencial de ser mu …

La ciencia del color en el diseño web: Cómo los colores influyen en la percepción y la experiencia del usuario Read More »

Scroll to Top